MESTINON Side Effects

6932691-5 | Condition Aggravated, Lung Disorder, Myasthenia Gravis, Nosocomial Infection, Respiratory Failure, Salivary Hypersecretion
on Aug 09, 2010 Male patient from FRANCE , 74 years of age, was diagnosed with myasthenia gravis and was treated with Mestinon (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, lung disorder, myasthenia gravis, nosocomial infection, respiratory failure, salivary hypersecretion. Mestinon dosage: . During the same period patient was treated with MYTELASE (View Mytelase Review and Mytelase Label ). Patient was hospitalized.

6786707-X | Convulsion, Hypotension, Stupor, Tachycardia
Patient was taking Mestinon (View Usage). Patient had the following side effects: convulsion, hypotension, stupor, tachycardia on Jun 11, 2010 from GERMANY Additional patient health information: Male patient , 79 years of age, . Mestinon dosage: . Patient was hospitalized.

6702844-X | Fatigue, Feeling Abnormal, Malaise, Myalgia, Withdrawal Syndrome
Adverse event was reported on Apr 19, 2010 by a Female patient taking Mestinon (View Usage) (Dosage: ) was diagnosed with myasthenia gravis and. Location: UNITED KINGDOM , 65 years of age, After Mestinon was administered, patient had the following side effects: fatigue, feeling abnormal, malaise, myalgia, withdrawal syndrome. During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

6554004-3 | Asthenia, Muscular Weakness, No Therapeutic Response, Product Substitution Issue
on Jan 25, 2010 Female patient from UNITED STATES , weighting 258.0 lb, was diagnosed with myasthenia gravis and was treated with Mestinon (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, muscular weakness, no therapeutic response, product substitution issue. Mestinon dosage: 60 Mg.


6541058-3 | Abdominal Discomfort, Atrial Fibrillation, Muscular Weakness, Nausea, No Therapeutic Response, Oesophageal Pain, Product Formulation Issue, Product Substitution Issue
on Jan 11, 2010 Female patient from AUSTRALIA , 85 years of age, was diagnosed with myasthenia gravis and was treated with Mestinon (View Usage). Patient had the following side effects: abdominal discomfort, atrial fibrillation (What is atrial fibrillation?), muscular weakness, nausea (What is nausea?), no therapeutic response, oesophageal pain, product formulation issue, product substitution issue. Mestinon dosage: . During the same period patient was treated with FLECAINIDE (View Flecainide Review and Flecainide Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), WARFARIN (View Warfarin Review and Warfarin Label ), LOSEC (View Losec Review and Losec Label ). Patient was hospitalized.

6468060-4 | Abdominal Pain, Blood Pressure Systolic Abnormal, Diarrhoea, Salivary Hypersecretion, Tremor
Patient was taking Mestinon (View Usage). After Mestinon was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), blood pressure systolic abnormal, diarrhoea, salivary hypersecretion, tremor on Nov 23, 2009 from FRANCE Additional patient health information: Female patient , 53 years of age, . Mestinon dosage: . During the same period patient was treated with MYTELASE (View Mytelase Review and Mytelase Label ), IMUREL (View Imurel Review and Imurel Label ). Patient was hospitalized.

6383863-2 | Myasthenia Gravis Crisis
Adverse event was reported on Sep 29, 2009 by a Female patient taking Mestinon (View Usage) (Dosage: 1 1/2 To 2 Tablets Every Four Hours Po) was diagnosed with myasthenia gravis and. Location: UNITED STATES , 36 years of age, weighting 184.0 lb, Patient experienced the following unwanted or unexpected effects: myasthenia gravis crisis.

6327268-9 | Bradycardia, Intentional Overdose, Respiratory Failure, Somnolence, Suicide Attempt, Vomiting
on Aug 14, 2009 Female patient from GERMANY , 52 years of age, weighting 154.3 lb, was treated with Mestinon (View Usage). Patient had the following side effects: bradycardia, intentional overdose, respiratory failure, somnolence, suicide attempt, vomiting. Mestinon dosage: . Patient was hospitalized.

6313680-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hypertransaminasaemia
on Aug 10, 2009 Male patient from ITALY , 59 years of age, was diagnosed with myasthenia gravis and was treated with Mestinon (View Usage). After Mestinon was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hypertransaminasaemia. Mestinon dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6309978-2 | Accidental Overdose, Convulsion, Diarrhoea, Hyperhidrosis, Hypotension, Salivary Hypersecretion
Patient was taking Mestinon (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose, convulsion, diarrhoea, hyperhidrosis, hypotension, salivary hypersecretion on Aug 07, 2009 from FRANCE Additional patient health information: Male patient , 71 years of age, was diagnosed with myasthenia gravis and. Mestinon dosage: . Patient was hospitalized.

6285693-9 | Constipation, Dysphagia, Throat Irritation
Adverse event was reported on Jul 20, 2009 by a Female patient taking Mestinon (View Usage) (Dosage: ) was diagnosed with myasthenia gravis and. Location: UNITED STATES , 57 years of age, weighting 185.2 lb, Patient had the following side effects: constipation (What is constipation?), dysphagia, throat irritation. During the same period patient was treated with ACIPHEX (View Aciphex Review and Aciphex Label ), INSULIN (View Insulin Review and Insulin Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ).

6285029-3 | Abdominal Pain, Diarrhoea, Dyspnoea
on Jul 16, 2009 Female patient from POLAND , 73 years of age, weighting 88.18 lb, was diagnosed with thymoma and was treated with Mestinon (View Usage). After Mestinon was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea, dyspnoea. Mestinon dosage: . During the same period patient was treated with HELICID (View Helicid Review and Helicid Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), STAVERAN (View Staveran Review and Staveran Label ). Patient was hospitalized.

6259699-X | Condition Aggravated, Myasthenia Gravis, Product Friable, Product Substitution Issue
on Jul 06, 2009 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with myasthenia gravis and was treated with Mestinon (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, myasthenia gravis, product friable, product substitution issue. Mestinon dosage: 60 Mg 4-5 Times A Day Po.

6237397-6 | Constipation, Dysphagia, Throat Irritation
Patient was taking Mestinon (View Usage). Patient had the following side effects: constipation (What is constipation?), dysphagia, throat irritation on Jun 11, 2009 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 185.2 lb, was diagnosed with myasthenia gravis and. Mestinon dosage: . During the same period patient was treated with ACIPHEX (View Aciphex Review and Aciphex Label ), INSULIN (View Insulin Review and Insulin Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ). Patient was hospitalized.

6156748-4 | Asthenia, Muscular Weakness
Adverse event was reported on Apr 10, 2009 by a Female patient taking Mestinon (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 262.0 lb, After Mestinon was administered, patient had the following side effects: asthenia, muscular weakness.

6072037-0 | Affect Lability, Arthralgia, Bradyphrenia, Diplopia, Gait Disturbance, Hypertension, Joint Range Of Motion Decreased, Product Quality Issue
on Feb 05, 2009 Female patient from UNITED STATES , 56 years of age, weighting 121.0 lb, was diagnosed with myasthenia gravis and was treated with Mestinon (View Usage). Patient experienced the following unwanted or unexpected effects: affect lability, arthralgia, bradyphrenia, diplopia, gait disturbance, hypertension, joint range of motion decreased, product quality issue. Mestinon dosage: 80mg Bid Po.

5992264-8 | Insomnia, Psychotic Disorder
on Nov 28, 2008 Male patient from UNITED KINGDOM , 42 years of age, was treated with Mestinon (View Usage). Patient had the following side effects: insomnia, psychotic disorder (What is psychotic disorder?). Mestinon dosage: .

5992263-6 | Insomnia, Psychotic Disorder
Patient was taking Mestinon (View Usage). After Mestinon was administered, patient had the following side effects: insomnia, psychotic disorder (What is psychotic disorder?) on Nov 28, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 42 years of age, . Mestinon dosage: .

5919240-5 | Anorexia, Asthenia, Diarrhoea, Disease Progression, Dysphagia, Myasthenia Gravis, No Therapeutic Response, Overdose, Vision Blurred
Adverse event was reported on Oct 10, 2008 by a Male patient taking Mestinon (View Usage) (Dosage: ) was diagnosed with myasthenia gravis and. Location: UNITED STATES , 70 years of age, weighting 183.0 lb, Patient experienced the following unwanted or unexpected effects: anorexia, asthenia, diarrhoea, disease progression, dysphagia, myasthenia gravis, no therapeutic response, overdose, vision blurred. During the same period patient was treated with LOMOTIL (View Lomotil Review and Lomotil Label ), VENOGLOBULIN (View Venoglobulin Review and Venoglobulin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ), IMURAN (View Imuran Review and Imuran Label ). Patient was hospitalized.

5908299-7 | Condition Aggravated, Dyspnoea, Fatigue, Myasthenia Gravis, Product Counterfeit, Product Quality Issue
on Oct 02, 2008 Male patient from UNITED STATES , weighting 260.0 lb, was diagnosed with asthenia and was treated with Mestinon (View Usage). Patient had the following side effects: condition aggravated, dyspnoea, fatigue, myasthenia gravis, product counterfeit, product quality issue. Mestinon dosage: 2 - 60mg T.i.d. Oral. During the same period patient was treated with LANTOS (View Lantos Review and Lantos Label ), NOVLIN R (View Novlin R Review and Novlin R Label ), PEPCID (View Pepcid Review and Pepcid Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), HYDROCHLOROT (View Hydrochlorot Review and Hydrochlorot Label ), PROTONIX (View Protonix Review and Protonix Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ).

5890285-7 | Anorexia, Asthenia, Diarrhoea, Disease Progression, Dysphagia, Myasthenia Gravis, No Therapeutic Response, Overdose, Vision Blurred
on Sep 09, 2008 Male patient from UNITED STATES , 70 years of age, weighting 183.0 lb, was diagnosed with myasthenia gravis and was treated with Mestinon (View Usage). After Mestinon was administered, patient had the following side effects: anorexia, asthenia, diarrhoea, disease progression, dysphagia, myasthenia gravis, no therapeutic response, overdose, vision blurred. Mestinon dosage: . During the same period patient was treated with LOMOTIL (View Lomotil Review and Lomotil Label ), VENOGLOBULIN (View Venoglobulin Review and Venoglobulin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ), VITAMIN TAB (View Vitamin Tab Review and Vitamin Tab Label ). Patient was hospitalized.

5876675-7 | Choking, Condition Aggravated, Dysphagia, Therapeutic Response Decreased
Patient was taking Mestinon (View Usage). Patient experienced the following unwanted or unexpected effects: choking (What is choking?), condition aggravated, dysphagia, therapeutic response decreased on Sep 09, 2008 from UNITED STATES Additional patient health information: Female patient , 54 years of age, weighting 150.0 lb, was diagnosed with myasthenia gravis and. Mestinon dosage: 60 Mgs Q4-6 Hours Atc Po.

5862990-X | Dysphagia, Liver Abscess
Adverse event was reported on Aug 14, 2008 by a Male patient taking Mestinon (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 70 years of age, Patient had the following side effects: dysphagia, liver abscess. Patient was hospitalized.

5848357-9 | Convulsion, Hypotension, Intentional Overdose, Suicide Attempt
on Aug 07, 2008 Female patient from GERMANY , 38 years of age, weighting 176.4 lb, was treated with Mestinon (View Usage). After Mestinon was administered, patient had the following side effects: convulsion, hypotension, intentional overdose, suicide attempt. Mestinon dosage: . Patient was hospitalized.

5805373-0 | Muscle Spasms
on Jul 08, 2008 Female patient from UNITED STATES , weighting 221.0 lb, was diagnosed with myasthenia gravis and was treated with Mestinon (View Usage). Patient experienced the following unwanted or unexpected effects: muscle spasms. Mestinon dosage: 60 Mg 1 1/2 Qid Po.

5797980-9 | Muscle Spasms
Patient was taking Mestinon (View Usage). Patient had the following side effects: muscle spasms on Jul 01, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 221.0 lb, was diagnosed with myasthenia gravis and. Mestinon dosage: 60mg 1 1/2 Qid Po.

5706630-9 | Bacterial Infection, Bronchitis, Cardiac Arrest, Condition Aggravated, Cyanosis, Dyspnoea, Hypoxia, Myasthenia Gravis, Obstructive Airways Disorder
Adverse event was reported on Jan 12, 1998 by a Male patient taking Mestinon (View Usage) (Dosage: 480 Mg; Po) was diagnosed with myasthenia gravis and. Location: UNITED KINGDOM , 70 years of age, After Mestinon was administered, patient had the following side effects: bacterial infection (What is bacterial infection?), bronchitis (What is bronchitis?), cardiac arrest (What is cardiac arrest?), condition aggravated, cyanosis, dyspnoea, hypoxia, myasthenia gravis, obstructive airways disorder. During the same period patient was treated with RETINEC (View Retinec Review and Retinec Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), STILNOX (View Stilnox Review and Stilnox Label ), FLAXIPARINE (View Flaxiparine Review and Flaxiparine Label ), TEGELINE (View Tegeline Review and Tegeline Label ).

5671600-6 | Dermatitis Bullous, Erythema
on Oct 09, 2006 Female patient from CANADA , 33 years of age, was treated with Mestinon (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis bullous, erythema. Mestinon dosage: 120 Mg; Tid; Po. During the same period patient was treated with COCAINE (View Cocaine Review and Cocaine Label ).

5654460-9 | Glaucoma, Ovarian Disorder, Pregnancy, Premature Baby, Tooth Loss
on Feb 21, 2008 Female patient from UNITED STATES , 26 years of age, weighting 130.0 lb, was diagnosed with myasthenia gravis and was treated with Mestinon (View Usage). Patient had the following side effects: glaucoma (What is glaucoma?), ovarian disorder, pregnancy (What is pregnancy?), premature baby, tooth loss. Mestinon dosage: 60 Mg;tid;po : 60 Mg;prn;po. During the same period patient was treated with EXEDRIN (View Exedrin Review and Exedrin Label ), VITAMIN TAB (View Vitamin Tab Review and Vitamin Tab Label ).

5608252-7 | Prinzmetal Angina
Patient was taking Mestinon (View Usage). After Mestinon was administered, patient had the following side effects: prinzmetal angina on Jan 11, 2008 from FRANCE Additional patient health information: Male patient , 75 years of age, was diagnosed with myasthenia gravis and. Mestinon dosage: 60 Mg; Tid; Po; 30 Mg; Tid; Po. During the same period patient was treated with INDAPAMIDE (View Indapamide Review and Indapamide Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

5584535-4 | Dermatitis Bullous, Erythema, Rash Vesicular
Adverse event was reported on Oct 09, 2006 by a Female patient taking Mestinon (View Usage) (Dosage: 120 Mg;tid; Po) . Location: CANADA , 33 years of age, Patient experienced the following unwanted or unexpected effects: dermatitis bullous, erythema, rash vesicular. During the same period patient was treated with COCAINE (View Cocaine Review and Cocaine Label ).

5573361-8 | Asthenia, Chest Discomfort
on Dec 20, 2007 Male patient from UNITED STATES , weighting 175.0 lb, was diagnosed with myasthenia gravis and was treated with Mestinon (View Usage). Patient had the following side effects: asthenia, chest discomfort. Mestinon dosage: 1 1/2 Q 3 Hours.

5510796-3 | Atrioventricular Block Complete, Atrioventricular Block Second Degree, Bradycardia, Dizziness Postural, Myasthenia Gravis Crisis, Nodal Rhythm, Respiratory Distress, Ventricular Asystole
on Oct 26, 2007 Male patient from UNITED STATES , 60 years of age, was diagnosed with myasthenia gravis and was treated with Mestinon (View Usage). After Mestinon was administered, patient had the following side effects: atrioventricular block complete, atrioventricular block second degree, bradycardia, dizziness postural, myasthenia gravis crisis, nodal rhythm, respiratory distress, ventricular asystole. Mestinon dosage: 60 Mg;qid. During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), PLASMA (View Plasma Review and Plasma Label ). Patient was hospitalized.

5504058-8 | Atrioventricular Block, Syncope
Patient was taking Mestinon (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block, syncope on Oct 17, 2007 from UNITED STATES Additional patient health information: Male patient , 60 years of age, was diagnosed with myasthenia gravis and. Mestinon dosage: .

5422373-3 | Akathisia, Anxiety, Delirium, Persecutory Delusion
Adverse event was reported on Aug 08, 2007 by a Female patient taking Mestinon (View Usage) (Dosage: 300 Mg; Qd; Po) was diagnosed with psychotic disorder (What is psychotic disorder?) and. Location: FRANCE , 49 years of age, Patient had the following side effects: akathisia, anxiety (What is anxiety?), delirium, persecutory delusion. During the same period patient was treated with ARIPIPRAZOLE (15 Mg; ; Po) (View Aripiprazole Review and Aripiprazole Label ), FLUVOXAMINE MALEATE (100 Mg;) (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), TERCIAN (CYAMEMAZINE) (25 Mg;) (View Tercian (cyamemazine) Review and Tercian (cyamemazine) Label ), MEPRONIZINE (MEPRONIZINE) (View Mepronizine (mepronizine) Review and Mepronizine (mepronizine) Label ), THERALENE (ALIMEMAZINE TARTRATE) (View Theralene (alimemazine Tartrate) Review and Theralene (alimemazine Tartrate) Label ), TRANXENE (5 Mg;) (View Tranxene Review and Tranxene Label ). Patient was hospitalized.

5295757-4 | Acne, Gastrointestinal Disorder, Toxic Epidermal Necrolysis
on Mar 19, 2007 Female patient from UNITED KINGDOM , 15 years of age, was diagnosed with myasthenia gravis and was treated with Mestinon (View Usage). After Mestinon was administered, patient had the following side effects: acne (What is acne?), gastrointestinal disorder, toxic epidermal necrolysis. Mestinon dosage: 90 Mg; Qid; Po. During the same period patient was treated with PREDNISOLONE (Qd) (View Prednisolone Review and Prednisolone Label ), MINOCIN (View Minocin Review and Minocin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

5261505-7 | Blood Glucose Increased, Condition Aggravated, Herpes Zoster
on Feb 20, 2007 Male patient from UNITED STATES , 81 years of age, was diagnosed with myasthenia gravis, herpes zoster and was treated with Mestinon (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, condition aggravated, herpes zoster. Mestinon dosage: 60 Mg; Prn. During the same period patient was treated with PREDNISONE TAB (Po) (View Prednisone Tab Review and Prednisone Tab Label ), XOPENEX (View Xopenex Review and Xopenex Label ), SINGULAIR (View Singulair Review and Singulair Label ), ZOCOR ^DIEKMANN^ (View Zocor ^diekmann^ Review and Zocor ^diekmann^ Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), DUTASTERIDE (View Dutasteride Review and Dutasteride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5159211-2 | Cardiac Arrest
Patient was taking Mestinon (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?) on Nov 03, 2006 from FRANCE Additional patient health information: Male patient , 69 years of age, was diagnosed with muscular weakness and. Mestinon dosage: 60 Mg; Bid; Po. During the same period patient was treated with IMURAN (50 Mg; Tid; Po) (View Imuran Review and Imuran Label ), EPREX (10 Kiu; Tiw; Sc) (View Eprex Review and Eprex Label ), DALTEPARIN SODIUM (5 Kiu; Qd; Sc) (View Dalteparin Sodium Review and Dalteparin Sodium Label ), MEDROL (View Medrol Review and Medrol Label ), LANTUS (View Lantus Review and Lantus Label ), LASIX (View Lasix Review and Lasix Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ), DIFFU K (View Diffu K Review and Diffu K Label ).

5110887-5 | Toxic Epidermal Necrolysis
Adverse event was reported on Sep 08, 2006 by a Female patient taking Mestinon (View Usage) (Dosage: 90 Mg; Qid; Po) was diagnosed with myasthenia gravis and. Location: UNITED KINGDOM , 15 years of age, After Mestinon was administered, patient had the following side effects: toxic epidermal necrolysis. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MINOCIN MR (View Minocin Mr Review and Minocin Mr Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

5036867-6 | Aphasia, Cholinergic Syndrome, Confusional State, Convulsion, Disturbance In Attention, Feeling Hot, Flushing, Hot Flush, Hypoaesthesia Oral
on Jun 12, 2006 Female patient from UNITED STATES , 44 years of age, weighting 165.0 lb, was diagnosed with muscular weakness and was treated with Mestinon (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), cholinergic syndrome, confusional state, convulsion, disturbance in attention, feeling hot, flushing, hot flush, hypoaesthesia oral. Mestinon dosage: 30 Mg; Qid; Po. During the same period patient was treated with PROPRANOLOL HYDROCHLORIDE (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ). Patient was hospitalized.

5026947-3 | Flank Pain, Perinephric Effusion, Retroperitoneal Fibrosis
on May 29, 2006 Male patient from FRANCE , 72 years of age, was diagnosed with myasthenic syndrome and was treated with Mestinon (View Usage). Patient had the following side effects: flank pain, perinephric effusion, retroperitoneal fibrosis. Mestinon dosage: 240 Mg; Qd; Po. During the same period patient was treated with CORTAN (10 Mg; Qd; Po) (View Cortan Review and Cortan Label ), DOMPERIDONE (DOMPERIDONE) (3 Df; Qd; Po) (View Domperidone (domperidone) Review and Domperidone (domperidone) Label ), OMEPRAZOLE (3 Df; Qd; Po) (View Omeprazole Review and Omeprazole Label ), CELLCEPT (4 Df; Qd; Po) (View Cellcept Review and Cellcept Label ), TRAMADOL HCL (2 Df; Qd; Po) (View Tramadol Hcl Review and Tramadol Hcl Label ). Patient was hospitalized.

5015140-6 | Abdominal Pain, Pelvic Fibrosis
Patient was taking Mestinon (View Usage). After Mestinon was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), pelvic fibrosis on May 18, 2006 from FRANCE Additional patient health information: Male patient , 72 years of age, was diagnosed with myasthenic syndrome and. Mestinon dosage: 240 Mg; Qd; Po. During the same period patient was treated with PREDNISONE TAB (10 Mg; Qd; Po) (View Prednisone Tab Review and Prednisone Tab Label ), DOMPERIDONE (DOMPERIDONE) (3 Df; Qd; Po) (View Domperidone (domperidone) Review and Domperidone (domperidone) Label ), OMEPRAZOLE (20 Mg; Qd; Po) (View Omeprazole Review and Omeprazole Label ), CELLCEPT (4 Df; Qd; Po) (View Cellcept Review and Cellcept Label ), TRAMADOL HCL (2 Df; Qd; Po) (View Tramadol Hcl Review and Tramadol Hcl Label ). Patient was hospitalized.

4972166-6 | Accidental Exposure, Rash, Urticaria
Adverse event was reported on Apr 12, 2006 by a Female patient taking Mestinon (View Usage) (Dosage: Inadvertant Topical Application) . Location: UNITED STATES , weighting 130.0 lb, Patient experienced the following unwanted or unexpected effects: accidental exposure, rash (What is rash?), urticaria. Patient was hospitalized.

4932988-4 | Therapeutic Response Decreased
on Mar 02, 2006 Female patient from UNITED STATES , weighting 191.8 lb, was treated with Mestinon (View Usage). Patient had the following side effects: therapeutic response decreased. Mestinon dosage: 1 Qd.

4924593-0 | Condition Aggravated, Neuromyelitis Optica, Pyrexia
on Feb 06, 2006 Female patient from FRANCE , 74 years of age, weighting 92.59 lb, was diagnosed with neuromyelitis optica and was treated with Mestinon (View Usage). After Mestinon was administered, patient had the following side effects: condition aggravated, neuromyelitis optica, pyrexia. Mestinon dosage: 120 Mg; Qd; Po. During the same period patient was treated with TEGRETOL (600 Mg; Qd; Po) (View Tegretol Review and Tegretol Label ), BACLOFEN (40 Mg; Qd; Po) (View Baclofen Review and Baclofen Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ). Patient was hospitalized.

4898602-1 | Atrioventricular Block
Patient was taking Mestinon (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block on Jan 13, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 63 years of age, was diagnosed with ocular hypertension and. Mestinon dosage: 60 Mg; Bid; Po. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), RISEDRONIC ACID (View Risedronic Acid Review and Risedronic Acid Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ). Patient was hospitalized.

4895626-5 | Hypertension
Adverse event was reported on Jan 10, 2006 by a Female patient taking Mestinon (View Usage) (Dosage: 10 Mg; Tid; Po) was diagnosed with quadriplegia, encephalitis periaxialis diffusa, parkinsonism and. Location: SWITZERLAND , 77 years of age, Patient had the following side effects: hypertension. During the same period patient was treated with RILUZOLE (RILUZOLE) (50 Mg;bid;) (View Riluzole (riluzole) Review and Riluzole (riluzole) Label ), MADOPAR (MADOPAR) (12.5 Mg;tid;po) (View Madopar (madopar) Review and Madopar (madopar) Label ), BACOFEN (View Bacofen Review and Bacofen Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), CONDROSULF (View Condrosulf Review and Condrosulf Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CALCIMAGON D3 (View Calcimagon-d3 Review and Calcimagon-d3 Label ).

4892118-4 | Fall, Femoral Neck Fracture
on Jan 10, 2006 Female patient from FRANCE , 85 years of age, was treated with Mestinon (View Usage). After Mestinon was administered, patient had the following side effects: fall (What is fall?), femoral neck fracture. Mestinon dosage: 60 Mg; Qd; Po. During the same period patient was treated with ROHYPNOL (FLUNITRAZEPAM) (View Rohypnol (flunitrazepam) Review and Rohypnol (flunitrazepam) Label ), XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

4892091-9 | Pyrexia
on Jan 10, 2006 Female patient from FRANCE , 74 years of age, weighting 92.59 lb, was diagnosed with neuromyelitis optica and was treated with Mestinon (View Usage). Patient experienced the following unwanted or unexpected effects: pyrexia. Mestinon dosage: 60 Mg; Bid; Po. During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ). Patient was hospitalized.

4889929-8 | Agitation, Anger, Asthenia, Choking, Condition Aggravated, Coordination Abnormal, Dysarthria, Fatigue, Feeling Abnormal
Patient was taking Mestinon (View Usage). Patient had the following side effects: agitation, anger, asthenia, choking (What is choking?), condition aggravated, coordination abnormal, dysarthria, fatigue, feeling abnormal on Jan 23, 2006 from UNITED STATES Additional patient health information: Female patient , weighting 168.0 lb, was diagnosed with myasthenia gravis and. Mestinon dosage: 30 Mg Every 2 Hours Po.